Clinical Trial: A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of IL-1 Inhibitor in the Treatment of Refractory Bechet's Disease (China)

China, Oct. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of IL-1 Inhibitor in the Treatment of Refractory Bechet's Disease'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134726

Registration Time: 2026/10/20

Type: Interventional study

Primary Sponsor: Shandong Provincial Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343657

Published by HT Digital Content Services with permission from Health Daily Digest....